Dermatology Foundation Report issue

Foundation Phase 2 Phase 3

Organization Overview

First Clinical Trial
2011
NCT01498406
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

garlic (1 trial)

Drugs in Phase 2 Trials (1)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 3)

Alopecia Areata (Phase 3)

Lupus Erythematosus, Cutaneous (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2